HR1486-118

Introduced

To amend the Federal Food, Drug, and Cosmetic Act to clarify the Food and Drug Administration’s jurisdiction over certain tobacco products, and to protect jobs and small businesses involved in the sale, manufacturing, and distribution of traditional and premium cigars.

118th Congress Introduced Mar 9, 2023

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

The bill creates limitation of authority with respect to premium cigars Section 901(c) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. It relies on definition changes, grants, compliance mandates, and exemptions. The main policy areas are Healthcare Consumers, Finance, and Healthcare.

Who Benefits and How

Patients and health care consumers affected by the bill could face lower compliance burdens and Businesses and employers affected by the bill could face lower compliance burdens.

Who Bears the Burden and How

Federal, state, or local agencies responsible for implementing the clause would take on compliance duties and Public beneficiaries or protected communities affected by the clause could face increased risk.

Key Provisions

  • Creates limitation of authority with respect to premium cigars Section 901(c) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

The bill creates limitation of authority with respect to premium cigars Section 901(c) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.

Key Policy Areas

Healthcare Consumers, Finance, Healthcare

Primary Purpose

The bill creates limitation of authority with respect to premium cigars Section 901(c) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.

Policy Domains

Healthcare Consumers Finance Healthcare

Whole bill

Identified Gains
  • Patients and health care consumers affected by the bill
  • Businesses and employers affected by the bill
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: ih
Businesses and employers affected by the bill:
Patients and health care consumers affected by the bill:
Identified Costs
  • Federal, state, or local agencies responsible for implementing the clause
  • Public beneficiaries or protected communities affected by the clause
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: ih
Public beneficiaries or protected communities affected by the clause:
Federal, state, or local agencies responsible for implementing the clause:

Legislative Progress

Introduced
Introduced Committee Passed
Mar 9, 2023

Ms. Castor of Florida (for herself and Mr. Posey) introduced …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Consumers Finance Healthcare

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology